Weight Gain in Risperidone Therapy Investigation of Peripheral Hypothalamic Neurohormone Levels in Psychotic Patients

Date

2013-10-01

Author

Yanık, Tülin
Sutcigil, Levent
Ak, Mehmet

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

185
views

0
downloads

The use of antipsychotic drugs has started a new era in the treatment of psychotic disorders. Nevertheless, they cause complications in the long-term treatment, which is mainly weight gain. In this study, we investigated circulating levels of hypothalamic neuropeptides, which are related to appetite regulation, neuropeptide Y (NPY), alpha-melanocyte-stimulating hormone (alpha-MSH), cocaine- and amphetamine-regulated transcript (CART), and leptin, in first-attack psychotic patients who were treated with an atypical antipsychotic drug, risperidone, for 4 weeks. We used a case-control association design to compare the neuropeptides in the control group versus before and after treatment of the patient group. Samples were obtained from psychotic patients who were admitted to the Psychiatry Outpatient Clinics, Gulhane School of Medicine, Ankara, Turkey. When compared with the control group, NPY and alpha-MSH plasma levels of psychotic patients were severely reduced, and the CART levels were substantially increased when they were first diagnosed (before treatment). However, the patients' body mass index and circulating leptin levels were markedly high after the treatment. Circulating levels of those neurohormones were not significantly changed between before and after treatment of the patients. These data demonstrate that peripheral alpha-MSH and NPY, although reflecting only secretion from peripheral organs, nevertheless, may provide an insight into the patients sympathetic tone and also suggest change of their appetite regulation. alpha-Melanocyte-stimulating hormone, NPY, and CART plasma levels may be used as a predictor of weight gain in the early treatment of the patients along with the leptin levels.

Subject Keywords

Pharmacology (medical), Psychiatry and Mental health

URI

https://hdl.handle.net/11511/46747

Journal

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

DOI

https://doi.org/10.1097/jcp.0b013e318297980e

Collections

Department of Biology, Article

Suggestions

OpenMETU
Core

HOW DYSFUNCTIONAL ARE THE DYSFUNCTIONAL ATTITUDES IN ANOTHER CULTURE SAHIN, NH; SAHIN, N (Wiley, 1992-03-01) The Dysfunctional Attitude Scale (DAS-A) has been used in many studies to measure depressogenic attitudes, vulnerability to depression and to assess the effectiveness of cognitive therapy. Despite its frequent use in research, no data have yet been reported on its item validity. The purpose of the present study was to investigate the item validity and psychometric properties of the DAS-A in the Turkish cultural context. The subjects were 345 university students. The locally adapted versions of the Beck ...
Psychometric properties of the Hamilton Depression Rating Scale and other physician-rated psychiatric scales for the assessment of depression in ESRD patients undergoing hemodialysis in Turkey Gençöz, Faruk; Gençöz, Tülin (Informa UK Limited, 2007-08-01) This study aimed to examine the reliability and validity of clinician-rated psychiatric scales for end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) treatment in Turkey. For this, the Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Global Assessment of Functioning (GAF) Scale, Clinical Global Impression (CGI) Scale, and Mini Mental State Exam (MMSE) were administered to 45 ESRD outpatients undergoing HD treatment. Regarding the reliability of HDRS and HARS, ...
Fluoxetine, not donepezil, reverses anhedonia, cognitive dysfunctions and hippocampal proteome changes during repeated social defeat exposure Gottschalk, M. G.; Mortas, P.; Haman, M.; Özcan Kabasakal, Süreyya; Biemans, B.; Bahn, S. (Elsevier BV, 2018-01-01) While anhedonia is considered a core symptom of major depressive disorder (MDD), less attention has been paid to cognitive dysfunctions. We evaluated the behavioural and molecular effects of a selective serotonin re-uptake inhibitor (SSRI, fluoxetine) and an acetylcholinesterase inhibitor (AChEI, donepezil) on emotional-cognitive endophenotypes of depression and the hippocampal proteome. A chronic social defeat (SD) procedure was followed up by "reminder" sessions of direct and indirect SD. Anhedonia-relate...
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder? Schepers, Elaine; et. al. (Frontiers Media SA, 2019-09-25) Introduction: White noise speech illusions index liability for psychotic disorder in case-control comparisons. In the current study, we examined i) the rate of white noise speech illusions in siblings of patients with psychotic disorder and ii) to what degree this rate would be contingent on exposure to known environmental risk factors (childhood adversity and recent life events) and level of known endophenotypic dimensions of psychotic disorder [psychotic experiences assessed with the Community Assessment ...
Factors associated with the symptoms of depression and anxiety among male Turkish prisoners: a life crisis and personal growth model perspective ŞENOL DURAK, EMRE; Gençöz, Faruk (Informa UK Limited, 2010-01-01) The factors associated with depression and anxiety disorders in the prison populations have been empirically tested in various studies. The aim of the present study was to examine the factors associated with the symptoms of depression and anxiety in a sample of 179 Turkish male prisoners. For this purpose, a model conceptualized by Schaefer and Moos (1998) was used as the theoretical framework for this study. The role of locus of control (as a personality trait); prison type, crime type, time spent in priso...

Citation Formats

T. Yanık, L. Sutcigil, and M. Ak, “Weight Gain in Risperidone Therapy Investigation of Peripheral Hypothalamic Neurohormone Levels in Psychotic Patients,” JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, pp. 608–613, 2013, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/46747.